Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
25.00
-20.55
-82.20%
Share Warrants & Outstandings
Total Reserve
-6.44
17.16
-23.60
-137.53%
Shareholder's Funds
-1.99
42.16
-44.15
-104.72%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
8.09
0.37
7.72
2,086.49%
Secured Loans
5.10
0.00
5.10
0.00%
Unsecured Loans
2.99
0.37
2.62
708.11%
Deferred Tax Assets / Liabilities
-0.19
0.93
-1.12
-120.43%
Other Long Term Liabilities
0.00
1.62
-1.62
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.51
2.93
4.58
156.31%
Current Liabilities
Trade Payables
10.22
33.87
-23.65
-69.83%
Other Current Liabilities
2.24
24.10
-21.86
-90.71%
Short Term Borrowings
0.00
39.62
-39.62
-100.00%
Short Term Provisions
0.59
0.00
0.59
0.00%
Total Current Liabilities
13.04
97.59
-84.55
-86.64%
Total Liabilities
18.56
142.68
-124.12
-86.99%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
17.69
23.32
-5.63
-24.14%
Less: Accumulated Depreciation
9.72
0.00
9.72
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.97
23.32
-15.35
-65.82%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
15.07
-15.07
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
7.09
-6.69
-94.36%
Long Term Loans & Advances
0.18
11.98
-11.80
-98.50%
Other Non Current Assets
0.00
18.25
-18.25
-100.00%
Total Non-Current Assets
8.56
75.70
-67.14
-88.69%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.31
25.62
-22.31
-87.08%
Sundry Debtors
1.28
15.54
-14.26
-91.76%
Cash and Bank
0.09
17.66
-17.57
-99.49%
Other Current Assets
0.00
3.97
-3.97
-100.00%
Short Term Loans and Advances
5.32
4.18
1.14
27.27%
Total Current Assets
10.00
66.97
-56.97
-85.07%
Net Current Assets (Including Current Investments)
-3.03
-30.62
27.59
90.10%
Total Current Assets Excluding Current Investments
10.00
66.97
-56.97
-85.07%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
18.56
142.68
-124.12
-86.99%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.32
39.99
-32.67
-81.70%
Book Value per share (adjusted)
-4.47
16.86
-21.33
-126.51%
Annual - Borrowings
Borrowings 7.70 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Annual - Investments
Investments 0.40 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024






